BotanicLab Intentional Rx Lacing Alleged In Amended Lawsuit
This article was originally published in The Tan Sheet
Executive Summary
An amended class action complaint against PC-SPES marketer BotanicLab alleges company representatives intentionally mixed the Rx ingredients alprazolam, indomethacin and diethylstilbestrol (DES) into seven other dietary supplement products
You may also be interested in...
NCCAM PC-SPES Clinical Research Could Resume With “Clean” Product
NIH's National Center for Complementary & Alternative Medicine could resume funding clinical research on PC-SPES if an independent manufacturer is able to develop an uncontaminated version of the proprietary herbal blend, NCCAM Director Stephen Straus, MD, suggested at the center's advisory council meeting in Rockville, Md. Aug. 26
NCCAM PC-SPES Clinical Research Could Resume With “Clean” Product
NIH's National Center for Complementary & Alternative Medicine could resume funding clinical research on PC-SPES if an independent manufacturer is able to develop an uncontaminated version of the proprietary herbal blend, NCCAM Director Stephen Straus, MD, suggested at the center's advisory council meeting in Rockville, Md. Aug. 26
NCCAM PC-SPES Clinical Research Could Resume With “Clean” Product
NIH's National Center for Complementary & Alternative Medicine could resume funding clinical research on PC-SPES if an independent manufacturer is able to develop an uncontaminated version of the proprietary herbal blend, NCCAM Director Stephen Straus, MD, suggested at the center's advisory council meeting in Rockville, Md. Aug. 26